TIMP1 and rheumatoid arthritis: Data in Figure 6A shows that 12.5 μM of sclareol decreased the expression of IL-1β-induced MMP1, but not TIMP-1, which suggests that sclareol suppresses the degradation of extracellular matrix (ECM) caused by RA.